| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| ChiCTR2100050901 |
The Affiliated Cancer Hospital of Guizhou Medical University |
HER-2 positive metastatic/recurrent breast cancer |
Therapy Study |
Post-market |
2021-09-26 | 939 | Patient list |
| ChiCTR2000040177 |
The Affiliated Cancer Hospital of Guizhou Medical University |
CD20-positive (CD20+) relapsed or refractory diffuse large B-cell lymphoma (DLBCL) |
Therapy Study |
Premarket |
2020-11-14 | 968 | Patient list |